select a format

Single User License
USD 5995 INR 387817
Site License
USD 11990 INR 775633
Corporate User License
USD 17985 INR 1163450

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


France Diabetes Care Devices Market Outlook to 2022-Glucose Monitoring and Insulin Delivery

France Diabetes Care Devices Market Outlook to 2022-Glucose Monitoring and Insulin Delivery


  • Products Id :- GDMEMC0198DB
  • |
  • Pages: 141
  • |
  • January 2017
  • |
  • |
  Request for Sample Report

Executive Summary

France Diabetes Care Devices Market Outlook to 2022-Glucose Monitoring and Insulin Delivery

Summary

GlobalData's new report, "France Diabetes Care Devices Market Outlook to 2022", provides key market data on the France Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size for Diabetes Care Devices market categories-Glucose Monitoring and Insulin Delivery.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.

2015 company shares and distribution shares data for Diabetes Care Devices market.

Global corporate-level profiles of key companies operating within the France Diabetes Care Devices market.

Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to Buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Diabetes Care Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Diabetes Care Devices Market, France 11

3.1 Diabetes Care Devices Market, France, Revenue ($m), 2008-2022 11

3.2 Diabetes Care Devices Market, France, Revenue Mix ($m), 2015 12

3.3 Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2015 13

3.4 Diabetes Care Devices Market, France, Revenue ($m), 2008-2015 14

3.5 Diabetes Care Devices Market, France, Revenue ($m), 2015-2022 16

3.6 Diabetes Care Devices Market, France, Volume (Units), 2008-2022 18

3.7 Diabetes Care Devices Market, France, Volume (Units), 2008-2015 19

3.8 Diabetes Care Devices Market, France, Volume (Units), 2015-2022 21

3.9 Diabetes Care Devices Market, France, Company Share by Revenue ($m), 2015 23

4 Glucose Monitoring Market, France 25

4.1 Glucose Monitoring Market, France, Revenue Mix ($m), 2015 25

4.2 Glucose Monitoring Market, France, Segment Contribution (%), 2015 26

4.3 Glucose Monitoring Market, France, Revenue ($m), 2008-2015 27

4.4 Glucose Monitoring Market, France, Revenue ($m), 2015-2022 29

4.4.1 Blood Glucose Meters Market, France, Revenue ($m), by Segment, 2008-2015 31

4.4.2 Blood Glucose Meters Market, France, Revenue ($m), by Segment, 2015-2022 33

4.5 Glucose Monitoring Market, France, Volume (Units), 2008-2015 35

4.6 Glucose Monitoring Market, France, Volume (Units), 2015-2022 37

4.6.1 Blood Glucose Meters Market, France, Volume (Units), by Segment, 2008-2015 39

4.6.2 Blood Glucose Meters Market, France, Volume (Units), by Segment, 2015-2022 41

4.7 Glucose Monitoring Market, France, Distribution Share by Revenue ($m), 2014-2015 43

4.8 Glucose Monitoring Market, France, Company Share by Revenue ($m), 2015 44

5 Insulin Delivery Market, France 46

5.1 Insulin Delivery Market, France, Revenue Mix ($m), 2015 46

5.2 Insulin Delivery Market, France, Segment Contribution (%), 2015 47

5.3 Insulin Delivery Market, France, Revenue ($m), 2008-2015 48

5.4 Insulin Delivery Market, France, Revenue ($m), 2015-2022 50

5.4.1 Insulin Pens Market, France, Revenue ($m), by Segment, 2008-2015 52

5.4.2 Insulin Pumps Market, France, Revenue ($m), by Segment, 2008-2015 54

5.4.3 Insulin Pens Market, France, Revenue ($m), by Segment, 2015-2022 55

5.4.4 Insulin Pumps Market, France, Revenue ($m), by Segment, 2015-2022 57

5.5 Insulin Delivery Market, France, Volume (Units), 2008-2015 59

5.6 Insulin Delivery Market, France, Volume (Units), 2015-2022 61

5.6.1 Insulin Pens Market, France, Volume (Units), by Segment, 2008-2015 63

5.6.2 Insulin Pumps Market, France, Volume (Units), by Segment, 2008-2015 65

5.6.3 Insulin Pens Market, France, Volume (Units), by Segment, 2015-2022 66

5.6.4 Insulin Pumps Market, France, Volume (Units), by Segment, 2015-2022 68

5.7 Insulin Delivery Market, France, Distribution Share by Revenue ($m), 2014-2015 70

5.8 Insulin Delivery Market, France, Company Share by Revenue ($m), 2015 71

6 Overview of Key Companies in France, Diabetes Care Devices Market 73

6.1 Sanofi 73

6.1.1 Company Overview 73

6.2 F. Hoffmann-La Roche Ltd 73

6.2.1 Company Overview 73

6.3 LifeScan Inc 73

6.3.1 Company Overview 73

6.4 Bayer HealthCare AG 73

6.4.1 Company Overview 73

6.5 Eli Lilly and Company 74

6.5.1 Company Overview 74

6.6 Abbott Laboratories 74

6.6.1 Company Overview 74

6.7 Medtronic plc 74

6.7.1 Company Overview 74

6.8 Novo Nordisk A/S 75

6.8.1 Company Overview 75

6.9 Ypsomed Holding AG 75

6.9.1 Company Overview 75

6.10 Becton Dickinson and Co 75

6.10.1 Company Overview 75

6.11 Arkray Inc 76

6.11.1 Company Overview 76

7 Diabetes Care Devices Market Pipeline Products 77

8 Financial Deals Landscape 78

8.1 Equity Offerings 78

8.1.1 Defymed Receives Investment from JDRF 78

8.2 Partnerships 79

8.2.1 Defymed Enters into Agreement with Semma Therapeutics 79

8.2.2 Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 80

8.2.3 Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche 81

8.2.4 Medtronic and Qualcomm Life Enter into Co-Development Agreement 82

8.2.5 Metabolon Enters into Licensing Agreement with Synlab 83

8.2.6 Cellnovo Enters into Agreement with Roche Diagnostics 84

9 Recent Developments 85

9.1 Corporate Communications 85

9.1.1 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare 85

9.1.2 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation 85

9.1.3 Sep 06, 2016: Sanofi Board Of Directors Provides Update 86

9.1.4 Aug 15, 2016: MMJ PhytoTech to Commence Phase 2 Clinical Trial on Pediatric Epilepsy 86

9.1.5 May 23, 2016: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 87

9.1.6 May 05, 2016: Encore Vision Announces Successful Phase I-II Study of Topical EV06 for the Treatment of Presbyopia 88

9.1.7 Mar 29, 2016: Sanofi Appoints Dr. Yong-Jun Liu as Head of Research 90

9.1.8 Mar 10, 2016: Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer 90

9.2 Financial Announcements 91

9.2.1 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results 91

9.2.2 Aug 16, 2016: vTv Therapeutics Completes Enrollment of Phase 2 Trial Evaluating TTP273 for the Treatment of Type 2 Diabetes 98

9.2.3 Aug 16, 2016: OncoGenex Announced Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer 100

9.2.4 Jul 29, 2016: Sanofi Announces Q2 2016 Results 102

9.2.5 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi 110

9.2.6 Apr 29, 2016: Solid Performance in the First Quarter of 2016 with Business EPS up 5.3% at Constant Exchange Rates 111

9.2.7 Mar 14, 2016: Chiasma Initiates Phase 3 Trial to Support European Registration of Octreotide Capsules for Patients with Acromegaly 118

9.2.8 Feb 09, 2016: Sanofi Delivered 2015 Business EPS Up 8.5% On A Reported Basis And Stable At Constant Exchange Rates Consistent With Guidance 121

9.3 Government and Public Interest 129

9.3.1 Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation's Board 129

9.3.2 Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation's Board of Directors 130

9.4 Other Significant Developments 130

9.4.1 May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation's Board 130

9.4.2 Apr 19, 2016: Sanofi Invests EUR300 Million To Expand Biologics Site in Belgium 134

9.4.3 Apr 19, 2016: Sanofi Invests EUR300 Million in its Biologics Site in Belgium to Develop its Monoclonal Antibodies Portfolio 134

9.5 Strategy And Business Planning 135

9.5.1 Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information 135

9.5.2 Apr 19, 2016: Sanofi Invests EUR300 Million To Expand Biologics Site in Belgium 136

10 Appendix 137

10.1 Research Methodology 138

10.1.1 Coverage 138

10.1.2 Secondary Research 138

10.1.3 Primary Research 139

10.1.4 Company Share Analysis 139

10.1.5 Distribution Share Analysis 139

10.1.6 Benchmarking 140

10.2 GlobalData Consulting 140

10.3 Contact Us 140

10.4 Disclaimer 141

1.2 List of Figures

Figure 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2008-2022 11

Figure 2: Diabetes Care Devices Market, France, Revenue Mix ($m), 2015 12

Figure 3: Diabetes Care Devices Market, France, Category Contribution (%), 2015 13

Figure 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 14

Figure 5: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 16

Figure 6: Diabetes Care Devices Market, France, Volume (Units), 2008-2022 18

Figure 7: Diabetes Care Devices Market, France, Volume (Units), Historic, 2008-2015 19

Figure 8: Diabetes Care Devices Market, France, Volume (Units), Forecast, 2015-2022 21

Figure 9: Diabetes Care Devices Market, France, Company Share (%) 2015 23

Figure 10: Glucose Monitoring Market, France, Revenue Mix ($m), 2015 25

Figure 11: Glucose Monitoring Market, France, Segment Contribution (%), 2015 26

Figure 12: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 27

Figure 13: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 29

Figure 14: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 31

Figure 15: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 33

Figure 16: Glucose Monitoring Market, France, Volume (Units), Historic, 2008-2015 35

Figure 17: Glucose Monitoring Market, France, Volume (Units), Forecast, 2015-2022 37

Figure 18: Blood Glucose Meters Market, France, Volume (Units), Historic, 2008-2015 39

Figure 19: Blood Glucose Meters Market, France, Volume (Units), Forecast, 2015-2022 41

Figure 20: Glucose Monitoring Market, France, Company Share (%) 2015 44

Figure 21: Insulin Delivery Market, France, Revenue Mix ($m), 2015 46

Figure 22: Insulin Delivery Market, France, Segment Contribution (%), 2015 47

Figure 23: Insulin Delivery Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 48

Figure 24: Insulin Delivery Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 50

Figure 25: Insulin Pens Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 52

Figure 26: Insulin Pumps Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 54

Figure 27: Insulin Pens Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 55

Figure 28: Insulin Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 57

Figure 29: Insulin Delivery Market, France, Volume (Units), Historic, 2008-2015 59

Figure 30: Insulin Delivery Market, France, Volume (Units), Forecast, 2015-2022 61

Figure 31: Insulin Pens Market, France, Volume (Units), Historic, 2008-2015 63

Figure 32: Insulin Pumps Market, France, Volume (Units), Historic, 2008-2015 65

Figure 33: Insulin Pens Market, France, Volume (Units), Forecast, 2015-2022 66

Figure 34: Insulin Pumps Market, France, Volume (Units), Forecast, 2015-2022 68

Figure 35: Insulin Delivery Market, France, Company Share (%) 2015 71

1.1 List of Tables

Table 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2008-2022 11

Table 2: Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2015 13

Table 3: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 15

Table 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 17

Table 5: Diabetes Care Devices Market, France, Volume (Units), 2008-2022 18

Table 6: Diabetes Care Devices Market, France, Volume (Units), Historic, 2008-2015 20

Table 7: Diabetes Care Devices Market, France, Volume (Units), Forecast, 2015-2022 22

Table 8: Diabetes Care Devices Market, France, Company Share by Revenue ($m), USD Constant, 2015 24

Table 9: Glucose Monitoring Market, France, Segment Contribution (%), 2015 26

Table 10: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 28

Table 11: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 30

Table 12: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 32

Table 13: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 34

Table 14: Glucose Monitoring Market, France, Volume (Units), Historic, 2008-2015 36

Table 15: Glucose Monitoring Market, France, Volume (Units), Forecast, 2015-2022 38

Table 16: Blood Glucose Meters Market, France, Volume (Units), Historic, 2008-2015 40

Table 17: Blood Glucose Meters Market, France, Volume (Units), Forecast, 2015-2022 42

Table 18: Glucose Monitoring Market, France, Distribution Share by Revenue ($m), USD Constant, 2014-2015 43

Table 19: Glucose Monitoring Market, France, Company Share by Revenue ($m), USD Constant, 2015 45

Table 20: Insulin Delivery Market, France, Segment Contribution (%), 2015 47

Table 21: Insulin Delivery Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 49

Table 22: Insulin Delivery Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 51

Table 23: Insulin Pens Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 53

Table 24: Insulin Pumps Market, France, Revenue ($m), USD Constant, Historic, 2008-2015 54

Table 25: Insulin Pens Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 56

Table 26: Insulin Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022 58

Table 27: Insulin Delivery Market, France, Volume (Units), Historic, 2008-2015 60

Table 28: Insulin Delivery Market, France, Volume (Units), Forecast, 2015-2022 62

Table 29: Insulin Pens Market, France, Volume (Units), Historic, 2008-2015 64

Table 30: Insulin Pumps Market, France, Volume (Units), Historic, 2008-2015 65

Table 31: Insulin Pens Market, France, Volume (Units), Forecast, 2015-2022 67

Table 32: Insulin Pumps Market, France, Volume (Units), Forecast, 2015-2022 69

Table 33: Insulin Delivery Market, France, Distribution Share by Revenue ($m), USD Constant, 2014-2015 70

Table 34: Insulin Delivery Market, France, Company Share by Revenue ($m), USD Constant, 2015 72

Table 35: Diabetes Care Devices Market Pipeline Products 77

Table 36: Defymed Receives Investment from JDRF 78

Table 37: Defymed Enters into Agreement with Semma Therapeutics 79

Table 38: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 80

Table 39: Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche 81

Table 40: Medtronic and Qualcomm Life Enter into Co-Development Agreement 82

Table 41: Metabolon Enters into Licensing Agreement with Synlab 83

Table 42: Cellnovo Enters into Agreement with Roche Diagnostics 84

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sanofi, F. Hoffmann-La Roche Ltd, LifeScan Inc, Bayer HealthCare AG, Eli Lilly and Company, Abbott Laboratories, Medtronic plc, Novo Nordisk A/S, Ypsomed Holding AG, Becton Dickinson and Co, Arkray Inc

Diabetes Care Devices, Glucose Monitoring, Insulin Delivery, Blood Glucose Meters, Lancets, Blood Glucose Test Strips, Insulin Pens, Insulin Syringes, Insulin Pumps, Traditional Insulin Pump Accessories, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic plc, Novo Nordisk A/S, Bayer HealthCare AG, Sanofi, Eli Lilly and Company, Abbott Laboratories, Becton Dickinson and Co, Arkray Inc, Animas Corp, Insulet Corp, Nipro Corp


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com